The U.S. FDA (Food and Drug Administration) has continuously monitored the ongoing response to the COVID-19 pandemic. The latest update from the FDA outlines their efforts to effectively oversee and improve ongoing actions. This update is available through an FDA news release that outlines:
- The FDA’s effort to protect consumers on the safety of drugs being marketed.
- An update on the combined actions of the FDA and Centers for Disease Control and Prevention (CDC) in monitoring the COVID-19 vaccine.
- The continual effort of the FDA to protect animals.
- Testing updates on devices that have been authorized by the FDA under emergency use authorizations (EUAs).
View the article released by the U.S. FDA at https://www.fda.gov/COVID-19 Update April 2021.
Stat One’s Response
Stat One has worked on COVID-19 related products including, diagnostic products, interventional trials, population-specific safety, and exploratory studies. Our team is dedicated to taking a focused approach to study design and analysis based on FDA guidance for COVID-19 products. We understand the importance of rapidly responding to the pandemic and the importance of working in a fast-paced environment. Our statistical team prioritizes client work when necessary to provide quick and accurate analyses and responses to questions.
View Stat One’s COVID-19 experience here: COVID-19 Brochure
For more information regarding the pandemic or to speak with the Stat One team about your COVID-19 product, please contact email@example.com.